Header Logo

Connection

PETER HIATT to Patient Selection

Back to Details
This is a "connection" page, showing publications PETER HIATT has written about Patient Selection.
PETER HIATT
Connection Strength
0.010
Patient Selection
  1. Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine. 2003 Jun 02; 21(19-20):2448-60.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.